The Power of PSMA-Targeted Therapy for Prostate Cancer

Prostate-specific membrane antigen, or PSMA, is a protein expressed on the surface of prostate cancer cells that has become an important target for both diagnosing and treating the disease. In this episode of CancerCast, Dr. Manish Shah speaks with prostate cancer expert Dr. Scott Tagawa about how this PSMA protein helps identify whether prostate cancer is confined to the prostate or has spread, and the ways it can be used to guide treatment decisions. They discuss how PSMA-based prostate cancer treatments work in the body and why these therapies have become one of the most significant recent advances in modern medicine for prostate cancer. Guest : Scott Tagawa, MD, MS, Director of the Genitourinary Oncology Program and Medical Director of the Genitourinary Oncology Research Program at Weill Cornell Medicine/NewYork-Presbyterian Hospital. Host: Manish Shah, MD, Chief of Solid Tumor Service and Director of Gastrointestinal Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

You can listen to The Power of PSMA-Targeted Therapy for Prostate Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

The Power of PSMA-Targeted Therapy for Prostate Cancer is an episode from CancerCast by Weill Cornell Medicine.

The episode duration depends on the source podcast feed and may not always be available.

This episode was published on Feb 13, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from CancerCast when more episodes are available from the podcast feed.